Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-06 - Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients.
16:45 - 18:00 | Presenter: Douglas W. Blayney | Author(s): Stephan Ogenstad, Yuankai Shi, Qingyuan Zhang, Lihua Du, Lan Huang, Ramon Mohanlal
- Abstract
Loading... -
+
P1.01-107 - The Impact of Anlotinib on Quality of Life in Patients with Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-108 - Management of Anlotinib-Related Adverse Events: Data From ALTER 0303
16:45 - 18:00 | Presenter: Li Zhang | Author(s): Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Jianxing He, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin, Baolan Li, Yinlan Chen, Jianying Zhou, Donglin Wang
- Abstract
Loading... -
+
P1.01-37 - BPI-9016M, a Novel c-Met Inhibitor, in Pretreated Advanced Solid Tumor: Results from a First-In-Human, Phase 1, Dose-Escalation Study
16:45 - 18:00 | Presenter: Xingsheng Hu | Author(s): Xin Zheng, Hongnan Mo, Xinhe Cui, Lieming Ding, Fenlai Tan, Pei Hu, Yuankai Shi
- Abstract
Loading...
-
+
P1.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.12-03 - A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
16:45 - 18:00 | Presenter: Yutao Liu | Author(s): Xingsheng Hu, Shengyu Zhou, Junling Li, Peng Liu, Yan Wang, Xueyu Hao, Yuankai Shi, Jun Jiang
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-18 - Exploring the Resistance Mechanism of Osimertinib and Monitoring the Treatment Response Using Plasma ctDNA in Chinese NSCLC Patients
16:45 - 18:00 | Presenter: Yuankai Shi | Author(s): Puyuan Xing, Xiaohong Han, Sha Wang, Yutao Liu, Peng Liu, Junling Li, Lianpeng Chang, Yanfang Guan, Zhishang Zhang, Di Wu, Jiarui Yao, Yi Xin
- Abstract
Loading... -
+
P1.13-25 - Efficacy and Safety of Osimertinib in EGFR T790M-Positive Advanced NSCLC Patients with Brain Metastases (APOLLO Study)
16:45 - 18:00 | Presenter: Ligang Xing | Author(s): Yueyin Pan, Yuankai Shi, Yongqian Shu, Jifeng Feng, Wei Li, Lejie Cao, Lifeng Wang, Wei Gu, Yong Song, Jinming Yu
- Abstract
Loading...
-
+
P2.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.17-13 - Genome-Wide Copy Number Alterations Profiling Predict Efficacy of Resected Stage II-IIIA Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Xiaohong Han | Author(s): Qiaoyun Tan, Teng Xiong, Sheng Yang, Wumin Dai, Dongmei Lin, Yong Zhou, Hua Lin, Yuankai Shi
- Abstract
Loading...